Our data in this study showed the expression of NF-κB, COX-2 and MMP-9 was suppressed upon berberine treatment, indicating that the anti-invasive effect of berberine may be associated with inflammation response of cancer cells upon treatment. This evidence concerns the gene PTGS2 and cancer.